Skip to main content
Clinical Trials/NCT00698854
NCT00698854
Active, Not Recruiting
N/A

A Prospective, Non-controlled, Clinical Investigation of the Vanguard™ Complete Knee System

Zimmer Biomet8 sites in 1 country600 target enrollmentMarch 2004

Overview

Phase
N/A
Intervention
Not specified
Conditions
Osteoarthritis
Sponsor
Zimmer Biomet
Enrollment
600
Locations
8
Primary Endpoint
KSS
Status
Active, Not Recruiting
Last Updated
2 years ago

Overview

Brief Summary

The purpose of this prospective clinical data-collection is to document the performance and clinical outcomes of the Vanguard™ Complete Knee System.

Detailed Description

This is a 10-year prospective observational data collection on the Vanguard Total Knee system. Patients are asked to come in for a preop, operative, immediate post-operative, 6 Month, 1 Year, 3 Year,5 Year, 7 year, and 10 year visits to check on the function, range of motion, and radiographic assessment of their total knee device. The Vanguard Knee is an FDA cleared device, and has been on the market since 2004.

Registry
clinicaltrials.gov
Start Date
March 2004
End Date
January 2026
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

KSS

Time Frame: 10 year

Knee Society Score Assessment

Secondary Outcomes

  • Radiographic Information(10 years)
  • Survivorship(10 years)

Study Sites (8)

Loading locations...

Similar Trials